Process for formulation of antibiotic compounds

Details for Australian Patent Application No. 2001261079 (hide)

Owner Merck & Co., Inc.

Inventors Hunke, William A.; Tsinontides, Stelios C.; Kanike, Anand; Al-Dehneh, Anthony; Illig, Kathleen J.; Reynolds, Scott D.; Patel, Hiren

Agent Spruson & Ferguson

Pub. Number AU-B-2001261079

PCT Pub. Number WO02/34750

Priority US00/29869 27.10.00 WO; 09698808 27.10.00 US

Filing date 27 April 2001

Wipo publication date 6 May 2002

Acceptance publication date 16 March 2006

International Classifications

C07D 477/20 (2006.01) Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

16 March 2006 Application Accepted

  Published as AU-B-2001261079

13 July 2006 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001261080

2001261078